Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saquinavir Switch for Indinavir-Associated Nephrotoxicity
NCT00477048Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- May 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saquinavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by HIV-NAT. Started May 2004; status: completed.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00477048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477048.